Free tool · about 4 minutes

Thinking of stopping? Make a plan first.

Most people who stop a GLP-1 medicine regain part of the weight. That isn’t failure. It’s a reason to plan, with your prescriber, before you stop.

Reviewed by the Kenning clinical and outcomes research team · Updated November 2026

This tool doesn’t tell you whether to stop. Your answers stay on this device.

2 in 3

people without diabetes stopped their GLP-1 medicine within a year, in a study of 125,474 US adults.

Rodriguez et al., JAMA Network Open, 2025

1

Why are you thinking of stopping?

Choose all that apply. Each reason changes your plan.

2

Your situation

Which medicine?

How long have you been taking it?

Do you have type 2 diabetes?

Your periods

3

How ready are you?

Honest answers make a better plan. “Not yet” is fine.

I’ve talked with my prescriber about stopping

I know whether to stop at once or step down the dose

I eat protein at every meal

I do strength training at least twice a week

I have recent Mirror Four numbers

I know what I’ll track, and when

I’ve agreed what would make me call my clinician

+ Where this comes from
  1. Rodriguez PJ, et al. Discontinuation and reinitiation of GLP-1 receptor agonists. JAMA Network Open, 2025.
  2. Wilding JPH, et al. Weight regain after withdrawal of semaglutide: STEP 1 extension. Diabetes, Obesity and Metabolism, 2022.
  3. Aronne LJ, et al. SURMOUNT-4. JAMA, 2024.
  4. Wegovy (semaglutide) prescribing information: pregnancy and stopping.
  5. Watson SL, et al. LIFTMOR. Journal of Bone and Mineral Research, 2018.
  6. Bauer J, et al. PROT-AGE protein recommendations. JAMDA, 2013.
  7. Nguyen N, Lu J. The Mirror and the Medicine, Chapters 7, 14 and 16. Kenning Health, 2027.

There is little trial evidence on whether stepping down the dose works better than stopping at once. Ask your prescriber. Kenning provides education, not medical advice, diagnosis or treatment.